Molecules/TRALOKINUMAB

TRALOKINUMAB

Molecular Identity

AntibodyApprovedFirst approved 2021

Mechanism of action: Interleukin-13 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

AdbryADTRALZACAT-354TralokinumabTRALOKINUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TRALOKINUMAB

Loading drug network...